CU20200096A7 - N-benzisoxazolil sulfonamidas como inhibidores de kat - Google Patents
N-benzisoxazolil sulfonamidas como inhibidores de katInfo
- Publication number
- CU20200096A7 CU20200096A7 CU2020000096A CU20200096A CU20200096A7 CU 20200096 A7 CU20200096 A7 CU 20200096A7 CU 2020000096 A CU2020000096 A CU 2020000096A CU 20200096 A CU20200096 A CU 20200096A CU 20200096 A7 CU20200096 A7 CU 20200096A7
- Authority
- CU
- Cuba
- Prior art keywords
- benzisoxazolyl
- sulfonamides
- kat
- inhibitors
- kat inhibitors
- Prior art date
Links
- -1 N-BENZISOXAZOLYL SULFONAMIDES Chemical class 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 229940124530 sulfonamide Drugs 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
- C07D261/20—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/423—Oxazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4245—Oxadiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/428—Thiazoles condensed with carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Peptides Or Proteins (AREA)
Abstract
<p>Un compuesto de la fórmula (I), o una sal farmacéutica del mismo.</p>
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1810092.5A GB201810092D0 (en) | 2018-06-20 | 2018-06-20 | Compounds |
| PCT/EP2019/066337 WO2019243491A1 (en) | 2018-06-20 | 2019-06-20 | Compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CU20200096A7 true CU20200096A7 (es) | 2021-08-06 |
Family
ID=63042663
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CU2020000096A CU20200096A7 (es) | 2018-06-20 | 2019-06-20 | N-benzisoxazolil sulfonamidas como inhibidores de kat |
Country Status (41)
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3471271A1 (en) | 2017-10-16 | 2019-04-17 | Acoustical Beauty | Improved convolutions of digital signals using a bit requirement optimization of a target digital signal |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| DK4299135T3 (da) * | 2019-06-18 | 2025-09-08 | Pfizer | Benzisoxazol-sulfonamid-derivater |
| US12545669B2 (en) | 2019-06-19 | 2026-02-10 | Pfizer Inc. | Cycloalkyl and heterocycloalkyl benzisoxazole sulfonamide derivatives |
| WO2021007663A1 (en) * | 2019-07-12 | 2021-01-21 | Canopy Growth Corporation | Cannabinoid derivatives |
| FI4181920T3 (fi) | 2020-07-15 | 2025-11-20 | Pfizer | Kat6-estäjämenetelmät ja yhdistelmät syövän hoitoon |
| US20240254139A1 (en) * | 2021-05-21 | 2024-08-01 | Aurigene Oncology Limited | Fused isoxazolyl compounds as kat6a inhibitors |
| CA3225068A1 (en) * | 2021-07-05 | 2023-01-12 | Hangzhou Innogate Pharma Co., Ltd. | Compound serving as kat6 inhibitor |
| US20250145637A1 (en) | 2021-08-10 | 2025-05-08 | Jiangsu Hengrui Pharmaceuticals Co. Ltd. | Sulfonamide derivative, preparation method therefor and medical use thereof |
| CN118556053A (zh) * | 2021-11-16 | 2024-08-27 | 英矽智能科技知识产权有限公司 | 赖氨酸乙酰基转移酶6a(kat6a)抑制剂及其用途 |
| WO2023114710A1 (en) * | 2021-12-13 | 2023-06-22 | Aurigene Oncology Limited | Fused benzoisoxazolyl compounds as kat6a inhibitors |
| CN116621859A (zh) * | 2022-02-18 | 2023-08-22 | 山东轩竹医药科技有限公司 | 三并环类kat6抑制剂 |
| KR20250006833A (ko) | 2022-03-28 | 2025-01-13 | 아이소스테릭스, 인코포레이티드 | 라이신 아세틸 전이효소의 myst 계열의 억제제 |
| CN119836416A (zh) * | 2022-06-16 | 2025-04-15 | 普莱鲁德疗法有限公司 | 具有泛素连接酶结合部分的靶向kat6的化合物 |
| JP2025533719A (ja) | 2022-07-29 | 2025-10-09 | ファイザー・インク | がんの治療のためのｋａｔ６阻害剤を含む投与レジメン |
| KR20250143814A (ko) | 2023-02-10 | 2025-10-02 | 지앙수 헨그루이 파마슈티컬스 컴퍼니 리미티드 | 설폰아미드 유도체 결정 형태 및 이의 제조 방법 |
| CN120981721A (zh) | 2023-03-30 | 2025-11-18 | 辉瑞大药厂 | Kat6a作为用kat6a抑制剂治疗的预测性生物标志物和相关治疗方法 |
| AR132470A1 (es) * | 2023-04-19 | 2025-07-02 | Insilico Medicine Ip Ltd | Inhibidor de lisina-acetiltransferasa 6a (kat6a), combinaciones y usos del mismo |
| KR20260016479A (ko) * | 2023-04-25 | 2026-02-03 | 인실리코 메디신 아이피 리미티드 | 결정질 리신 아세틸트랜스퍼라제 6a (kat6a) 억제제 및 그의 용도 |
| AU2024290895A1 (en) * | 2023-07-04 | 2026-01-29 | Shanghai Qilu Pharmaceutical Research And Development Centre Ltd. | Kat6 inhibitor |
| AU2024325442A1 (en) * | 2023-08-14 | 2026-03-26 | Shanghai Henlius Biologics Co., Ltd. | Sulfonamide compound, and preparation method therefor and use thereof |
| WO2025098417A1 (zh) * | 2023-11-08 | 2025-05-15 | 再和医药科技（苏州）有限公司 | 磺酰胺类化合物及其应用 |
Family Cites Families (112)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3064003A (en) | 1962-11-13 | Carboxylic acid derivatives of sub- | ||
| US2358031A (en) | 1944-09-12 | Substituted thiadiazoles | ||
| US2525321A (en) | 1949-01-07 | 1950-10-10 | American Cyanamid Co | Hydroxybenzenesulfonamidoisoxazoles and preparation of same |
| GB689281A (en) | 1950-02-18 | 1953-03-25 | Lunbeck Corp | Improvements in or relating to the production of sulphanilamido-thiadiazoles |
| DE1102745B (de) | 1959-06-06 | 1961-03-23 | Boehringer & Soehne Gmbh | Verfahren zur Herstellung von 5-Sulfanilamidoisoxazolen |
| BE617370A (fr) | 1961-05-09 | 1962-11-08 | Ciba Geigy | Procédé de préparation du 2,5-di-[benzoxazolyl-(2')]-thiofène |
| US3332942A (en) | 1962-11-02 | 1967-07-25 | White Lab Inc | Substituted thiadiazoles |
| JPS498255B1 (es) | 1970-10-08 | 1974-02-25 | ||
| US3960854A (en) | 1972-03-20 | 1976-06-01 | Merck & Co., Inc. | 7-Mercapto(or thio)-benzothiadiazine products |
| US3951967A (en) | 1972-03-20 | 1976-04-20 | Merck & Co., Inc. | 7-Mercapto(or thio)-benzothiadiazine products |
| DE2617809C2 (de) | 1976-04-23 | 1984-09-20 | Basf Ag, 6700 Ludwigshafen | Verfahren zur Stabilisierung von Chromdioxid-Magnetpigmenten und seine Verwendung |
| JPS6042794B2 (ja) | 1977-09-27 | 1985-09-25 | 三共株式会社 | イソオキサゾリウム塩，およびその製造方法 |
| US4251664A (en) | 1978-05-24 | 1981-02-17 | Henkel Corporation | Sulfonamidothiadiazoles, metal complexes thereof, and solutions containing such compounds for use in extraction of metal values |
| US4172896A (en) | 1978-06-05 | 1979-10-30 | Dainippon Pharmaceutical Co., Ltd. | Methane-sulfonamide derivatives, the preparation thereof and composition comprising the same |
| JPS603685B2 (ja) | 1980-04-15 | 1985-01-30 | 日本コロムビア株式会社 | 絵入りレコ−ド盤の製造方法 |
| GB8427618D0 (en) | 1984-11-01 | 1984-12-05 | Shell Int Research | Anticoccidial compositions |
| JPS63238006A (ja) | 1987-03-26 | 1988-10-04 | Shionogi & Co Ltd | イモチ防除剤 |
| US5962490A (en) | 1987-09-25 | 1999-10-05 | Texas Biotechnology Corporation | Thienyl-, furyl- and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| US5591761A (en) | 1993-05-20 | 1997-01-07 | Texas Biotechnology Corporation | Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| NZ231534A (en) | 1988-11-29 | 1992-02-25 | Warner Lambert Co | 3,5-di-t-butyl-4-hydroxyphenyl-triazoles, oxadiazoles and thiadiazoles; anti-inflammatory compositions |
| JPH03258771A (ja) | 1990-03-09 | 1991-11-19 | Tosoh Corp | スルホンアミド誘導体、その製法及びそれを有効成分として含有する除草剤 |
| JP2902834B2 (ja) | 1991-10-09 | 1999-06-07 | 本田技研工業株式会社 | 自己伸縮型マウント |
| TW224462B (es) | 1992-02-24 | 1994-06-01 | Squibb & Sons Inc | |
| FR2690160A1 (fr) | 1992-04-15 | 1993-10-22 | Rhone Poulenc Rorer Sa | Application de dérivés d'acide 2H-1,2,4-benzothiadiazine-1,1-dioxyde-3-carboxylique à la préparation de médicaments, les produits nouveaux, leur préparation et les médicaments les contenant. |
| NZ247440A (en) | 1992-05-06 | 1995-04-27 | Squibb & Sons Inc | Phenyl sulphonamide derivatives, preparation and pharmaceutical compositions thereof |
| FI941826L (fi) | 1993-04-21 | 1994-10-22 | Takeda Chemical Industries Ltd | Menetelmät ja koostumukset elimen hypofunktion ennaltaehkäisemiseksi ja/tai terapeuttiseksi hoitamiseksi |
| JP3901229B2 (ja) | 1994-05-13 | 2007-04-04 | Ｎｔｎ株式会社 | 耐熱・潤滑性樹脂組成物 |
| ATE243203T1 (de) | 1995-04-04 | 2003-07-15 | Texas Biotechnology Corp | Thienyl-, furyl-, pyrrolyl- und biphenylsulfonamide und derivate zur modulation der endothelin-aktivität |
| GB9624482D0 (en) | 1995-12-18 | 1997-01-15 | Zeneca Phaema S A | Chemical compounds |
| DE69720965T2 (de) | 1996-02-13 | 2004-02-05 | Astrazeneca Ab | Chinazolinderivate und deren verwendung als vegf hemmer |
| NZ331191A (en) | 1996-03-05 | 2000-03-27 | Zeneca Ltd | 4-anilinoquinazoline derivatives and pharmaceutical compositions thereof |
| US5804585A (en) | 1996-04-15 | 1998-09-08 | Texas Biotechnology Corporation | Thieno-pyridine sulfonamides derivatives thereof and related compounds that modulate the activity of endothelin |
| GB9718972D0 (en) | 1996-09-25 | 1997-11-12 | Zeneca Ltd | Chemical compounds |
| AU7179598A (en) | 1996-11-13 | 1998-06-03 | Cephalon, Inc. | Benzothiazo and related heterocyclic group-containing cysteine and serine protease inhibitors |
| CA2280930C (en) | 1997-02-12 | 2010-04-06 | The Regents Of The University Of Michigan | Protein markers for lung cancer and use thereof |
| US5783705A (en) | 1997-04-28 | 1998-07-21 | Texas Biotechnology Corporation | Process of preparing alkali metal salys of hydrophobic sulfonamides |
| JP3455233B2 (ja) | 1997-04-28 | 2003-10-14 | テキサス・バイオテクノロジー・コーポレイシヨン | エンドテリン介在障害治療用のスルホンアミド類 |
| GB9714249D0 (en) | 1997-07-08 | 1997-09-10 | Angiogene Pharm Ltd | Vascular damaging agents |
| GB9900334D0 (en) | 1999-01-07 | 1999-02-24 | Angiogene Pharm Ltd | Tricylic vascular damaging agents |
| GB9900752D0 (en) | 1999-01-15 | 1999-03-03 | Angiogene Pharm Ltd | Benzimidazole vascular damaging agents |
| PT1154774E (pt) | 1999-02-10 | 2005-10-31 | Astrazeneca Ab | Derivados de quinazolina como inibidores de angiogenese |
| CZ2002959A3 (cs) | 1999-09-17 | 2002-07-17 | Millennium Pharmaceuticals, Inc. | Inhibitory faktoru Xa |
| KR100881105B1 (ko) | 1999-11-05 | 2009-02-02 | 아스트라제네카 아베 | Ｖｅｇｆ 억제제로서의 퀴나졸린 유도체 |
| WO2001049289A1 (en) | 1999-12-31 | 2001-07-12 | Texas Biotechnology Corporation | Pharmaceutical and veterinary uses of endothelin antagonists |
| JP3663382B2 (ja) | 2000-02-15 | 2005-06-22 | スージェン・インコーポレーテッド | ピロール置換２−インドリノン蛋白質キナーゼ阻害剤 |
| WO2001064642A2 (en) | 2000-02-29 | 2001-09-07 | Cor Therapeutics, Inc. | Benzamides and related inhibitors of factor xa |
| AU2001258628A1 (en) | 2000-05-31 | 2001-12-11 | Astrazeneca Ab | Indole derivatives with vascular damaging activity |
| UA73993C2 (uk) | 2000-06-06 | 2005-10-17 | Астразенека Аб | Хіназолінові похідні для лікування пухлин та фармацевтична композиція |
| MXPA02012903A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como inhibidores de angiogenesis. |
| MXPA02012905A (es) | 2000-07-07 | 2004-07-30 | Angiogene Pharm Ltd | Derivados de colquinol como agentes de dano vascular.. |
| GB0127344D0 (en) | 2001-11-14 | 2002-01-02 | Cancer Res Ventures Ltd | Assay method |
| IL160630A0 (en) | 2001-11-22 | 2004-07-25 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1 |
| JP2003292485A (ja) | 2002-04-01 | 2003-10-15 | Yamanouchi Pharmaceut Co Ltd | スルホンアミド誘導体 |
| TW200505902A (en) | 2003-03-20 | 2005-02-16 | Schering Corp | Cannabinoid receptor ligands |
| WO2004103980A1 (en) | 2003-05-21 | 2004-12-02 | Biovitrum Ab | Inhibitors of 11-beta-hydroxy steroid dehydrogenase type i |
| WO2004113310A1 (en) | 2003-06-25 | 2004-12-29 | Biovitrum Ab | Use of an inhibitor of 11-b-hydroxysteroid dehydrogenase type 1 compounds for promoting wound healing |
| EP1660087A2 (en) | 2003-07-22 | 2006-05-31 | Janssen Pharmaceutica N.V. | Quinolinone derivatives as inhibitors of c-fms kinase |
| EP1673357A2 (en) | 2003-08-08 | 2006-06-28 | Vertex Pharmaceuticals Incorporated | Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| US7615563B2 (en) | 2003-08-08 | 2009-11-10 | Gonzalez Iii Jesus E | Compositions useful as inhibitors of voltage-gated sodium channels |
| US8614318B2 (en) * | 2003-11-13 | 2013-12-24 | Abbvie Inc. | Apoptosis promoters |
| US7973161B2 (en) | 2003-11-13 | 2011-07-05 | Abbott Laboratories | Apoptosis promoters |
| US7642260B2 (en) | 2003-11-13 | 2010-01-05 | Abbott Laboratories, Inc. | Apoptosis promoters |
| US7767684B2 (en) | 2003-11-13 | 2010-08-03 | Abbott Laboratories | Apoptosis promoters |
| RU2407736C2 (ru) | 2004-10-12 | 2010-12-27 | Декод Дженетикс Ехф | Пери-замещенные арилсульфонамидные бициклические соединения, предназначенные для лечения окклюзионного заболевания артерий |
| BRPI0610258A2 (pt) | 2005-04-26 | 2012-09-25 | Hypnion Inc | composto ou um sal farmaceuticamente eficaz do mesmo, composição farmacêutica, e, uso de um composto |
| AU2006239302B2 (en) | 2005-04-26 | 2011-07-07 | Hypnion, Inc. | Benzisoxazole piperazine compounds and methods of use thereof |
| CA2608599A1 (en) | 2005-05-16 | 2006-11-23 | Vertex Pharmaceuticals Incorporated | Bicyclic derivatives as modulators of ion channels |
| DE102005038947A1 (de) | 2005-05-18 | 2006-11-30 | Grünenthal GmbH | Substituierte Benzo[d]isoxazol-3-yl-amin-Verbindungen und deren Verwendung in Arzneimitteln |
| WO2007039175A1 (en) | 2005-10-06 | 2007-04-12 | Sanofi-Aventis | N-[1 ,3,4]-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| ATE513829T1 (de) | 2005-10-06 | 2011-07-15 | Sanofi Aventis | Bicyclische arylsulfonsäureä1,3,4ü-thiadiazol-2- yl-amide, verfahren zu ihrer herstellung und ihre verwendung als pharmazeutika |
| DE102005055355A1 (de) | 2005-11-21 | 2007-10-31 | Merck Patent Gmbh | 3,6-Dihydro-2-oxo-6H-[1,3,4]thiadiazinderivate |
| EP2316829A1 (en) | 2005-12-21 | 2011-05-04 | Vertex Pharmaceuticals Incorporated | Heterocyclic derivatives as modulators of ion channels |
| EP2054056A4 (en) | 2006-08-16 | 2010-08-25 | J David Gladstone Inst A Testa | SMALL MOLECULAR INHIBITORS OF KYNURENINE-3-MONOOXYGENASE |
| US20080182845A1 (en) | 2006-11-16 | 2008-07-31 | Abbott Laboratories | Method of preventing or treating organ, hematopoietic stem cell or bone marrow transplant rejection |
| CA2670031A1 (en) | 2006-11-20 | 2008-05-29 | Alantos Pharmaceuticals Holding, Inc. | Heterobicyclic metalloprotease inhibitors |
| US20080194557A1 (en) | 2007-01-18 | 2008-08-14 | Joseph Barbosa | Methods and compositions for the treatment of pain, inflammation and cancer |
| US8124610B2 (en) | 2007-07-13 | 2012-02-28 | Icagen Inc. | Sodium channel inhibitors |
| WO2009058348A1 (en) | 2007-11-01 | 2009-05-07 | Sirtris Pharmaceuticals, Inc. | Amide derivatives as sirtuin modulators |
| WO2009086303A2 (en) | 2007-12-21 | 2009-07-09 | University Of Rochester | Method for altering the lifespan of eukaryotic organisms |
| EP2240474B1 (en) | 2007-12-26 | 2012-03-14 | Sanofi | Cyclic pyridyl-n-(1,3,4)-thiadiazol-2-yl-benzene sulfonamides, processes for their preparation and their use as pharmaceuticals |
| CA2734254C (en) | 2008-08-13 | 2018-06-05 | Smed-Ta/Td, Llc | Orthopaedic screws |
| WO2010046780A2 (en) | 2008-10-22 | 2010-04-29 | Institut Pasteur Korea | Anti viral compounds |
| PE20120008A1 (es) * | 2009-01-12 | 2012-01-24 | Icagen Inc | Derivados de fenoxi bencenosulfonamida |
| WO2010121963A1 (en) | 2009-04-21 | 2010-10-28 | Nerviano Medical Sciences S.R.L. | Resorcinol derivatives as hsp90 inhibitors |
| UA107360C2 (en) | 2009-08-05 | 2014-12-25 | Biogen Idec Inc | Bicyclic aryl sphingosine 1-phosphate analogs |
| HRP20151258T1 (hr) | 2009-08-07 | 2016-02-26 | Chugai Seiyaku Kabushiki Kaisha | Derivat aminopirazola |
| WO2011082400A2 (en) | 2010-01-04 | 2011-07-07 | President And Fellows Of Harvard College | Modulators of immunoinhibitory receptor pd-1, and methods of use thereof |
| WO2011085575A1 (zh) | 2010-01-15 | 2011-07-21 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
| CN101747325A (zh) | 2010-01-15 | 2010-06-23 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
| CN101845043A (zh) | 2010-01-15 | 2010-09-29 | 江苏省农药研究所股份有限公司 | 邻杂环甲酰苯胺类化合物及其合成方法和应用 |
| US20130109672A1 (en) | 2010-04-29 | 2013-05-02 | The United States Of America,As Represented By The Secretary, Department Of Health And Human Service | Activators of human pyruvate kinase |
| TW201210597A (en) | 2010-06-09 | 2012-03-16 | Gilead Sciences Inc | Inhibitors of hepatitis C virus |
| JP2013532185A (ja) | 2010-07-12 | 2013-08-15 | ファイザー・リミテッド | 化合物 |
| WO2012080729A2 (en) | 2010-12-14 | 2012-06-21 | Electrophoretics Limited | CASEIN KINASE 1δ (CK1δ) INHIBITORS |
| US8987271B2 (en) | 2010-12-22 | 2015-03-24 | Eutropics Pharmaceuticals, Inc. | 2,2′-biphenazine compounds and methods useful for treating disease |
| US9464065B2 (en) | 2011-03-24 | 2016-10-11 | The Scripps Research Institute | Compounds and methods for inducing chondrogenesis |
| PL220630B1 (pl) | 2012-12-28 | 2015-11-30 | Inst Immunologii I Terapii Doświadczalnej Pan | Nowe sulfonamidowe pochodne izoksazolo[5,4-b]pirydyny o aktywności przeciwbakteryjnej, sposób ich wytwarzania oraz nowe zastosowanie 3-aminoizoksazolo[5,4-b]pirydyny |
| MX2015010775A (es) | 2013-03-15 | 2016-04-25 | Genentech Inc | Benzoxazoles sustituidos y metodos para usarlos. |
| WO2015102929A1 (en) | 2013-12-30 | 2015-07-09 | Novartis Ag | Tricyclic sulfonamide derivatives |
| WO2015112465A1 (en) | 2014-01-24 | 2015-07-30 | Merck Sharp & Dohme Corp. | Isoquinoline derivatives as mgat2 inhibitors |
| CA2946702C (en) * | 2014-04-23 | 2022-06-28 | Mitsubishi Tanabe Pharma Corporation | Bicyclic or tricyclic heterocyclic compound |
| JP5900759B2 (ja) | 2014-09-25 | 2016-04-06 | Toto株式会社 | 小便器 |
| MX2017010844A (es) | 2015-02-24 | 2017-12-07 | Pfizer | Derivados de nucleosidos sustituidos utiles como agentes anticancerosos. |
| GB201510019D0 (en) | 2015-06-09 | 2015-07-22 | Cancer Therapeutics Crc Pty Ltd | Compounds |
| WO2017002120A1 (en) | 2015-07-02 | 2017-01-05 | Yeda Research And Development Co. Ltd. | Selective inhibitors of senescent cells and uses thereof |
| WO2017098421A1 (en) | 2015-12-08 | 2017-06-15 | Glaxosmithkline Intellectual Property Development Limited | Benzothiadiazine compounds |
| CN107098846B (zh) | 2016-02-26 | 2020-10-09 | 中国医学科学院药物研究所 | N-酰基磺酰胺类FBPase抑制剂、其制备方法、药物组合物及用途 |
| JP2019533022A (ja) | 2016-10-24 | 2019-11-14 | ユマニティ セラピューティクス，インコーポレーテッド | 化合物及びその使用 |
| EP3548480A1 (en) * | 2016-11-29 | 2019-10-09 | Epizyme, Inc. | Compounds containing a sulfonic group as kat inhibitors |
| WO2018226976A1 (en) | 2017-06-08 | 2018-12-13 | Kura Oncology, Inc. | Methods and compositions for inhibiting the interaction of menin with mll proteins |
| GB201810092D0 (en) | 2018-06-20 | 2018-08-08 | Ctxt Pty Ltd | Compounds |
| DK4299135T3 (da) | 2019-06-18 | 2025-09-08 | Pfizer | Benzisoxazol-sulfonamid-derivater |
-
2018
- 2018-06-20 GB GBGB1810092.5A patent/GB201810092D0/en not_active Ceased
-
2019
- 2019-06-20 RS RS20231178A patent/RS64932B1/sr unknown
- 2019-06-20 AU AU2019289888A patent/AU2019289888A1/en not_active Abandoned
- 2019-06-20 TW TW108121417A patent/TWI826471B/zh active
- 2019-06-20 PL PL19734722.2T patent/PL3810602T3/pl unknown
- 2019-06-20 BR BR112020025869-5A patent/BR112020025869A2/pt unknown
- 2019-06-20 LT LTEPPCT/EP2019/066337T patent/LT3810602T/lt unknown
- 2019-06-20 US US16/446,868 patent/US20200039945A1/en not_active Abandoned
- 2019-06-20 EP EP23202715.1A patent/EP4335439A3/en not_active Withdrawn
- 2019-06-20 EA EA202092451A patent/EA202092451A1/ru unknown
- 2019-06-20 MA MA52948A patent/MA52948B1/fr unknown
- 2019-06-20 CN CN201980041013.4A patent/CN112334466B/zh active Active
- 2019-06-20 DK DK19734722.2T patent/DK3810602T3/da active
- 2019-06-20 ES ES19734722T patent/ES2967983T3/es active Active
- 2019-06-20 FI FIEP19734722.2T patent/FI3810602T3/fi active
- 2019-06-20 HR HRP20231467TT patent/HRP20231467T1/hr unknown
- 2019-06-20 SG SG11202010450VA patent/SG11202010450VA/en unknown
- 2019-06-20 IL IL279554A patent/IL279554B2/en unknown
- 2019-06-20 PT PT197347222T patent/PT3810602T/pt unknown
- 2019-06-20 HU HUE19734722A patent/HUE064744T2/hu unknown
- 2019-06-20 EP EP19734722.2A patent/EP3810602B1/en active Active
- 2019-06-20 UY UY0001038270A patent/UY38270A/es active IP Right Grant
- 2019-06-20 SI SI201930674T patent/SI3810602T1/sl unknown
- 2019-06-20 MX MX2020012723A patent/MX2020012723A/es unknown
- 2019-06-20 PY PY201901948644A patent/PY1948644A/es unknown
- 2019-06-20 KR KR1020217001354A patent/KR102868724B1/ko active Active
- 2019-06-20 MY MYPI2020006108A patent/MY208377A/en unknown
- 2019-06-20 JP JP2020571368A patent/JP2021529738A/ja not_active Withdrawn
- 2019-06-20 CA CA3101238A patent/CA3101238A1/en active Pending
- 2019-06-20 MD MDE20210392T patent/MD3810602T2/ro unknown
- 2019-06-20 WO PCT/EP2019/066337 patent/WO2019243491A1/en not_active Ceased
- 2019-06-20 CU CU2020000096A patent/CU20200096A7/es unknown
- 2019-06-20 GE GEAP201915535A patent/GEP20227403B/en unknown
- 2019-06-20 GE GEAP202215535A patent/GEAP202215535A/en unknown
- 2019-06-20 CR CR20210032A patent/CR20210032A/es unknown
- 2019-06-20 PE PE2020001917A patent/PE20210181A1/es unknown
- 2019-06-21 AR ARP190101711A patent/AR114972A1/es unknown
-
2020
- 2020-11-23 EC ECSENADI202075270A patent/ECSP20075270A/es unknown
- 2020-11-24 CO CONC2020/0014586A patent/CO2020014586A2/es unknown
- 2020-12-02 NI NI202000092A patent/NI202000092A/es unknown
- 2020-12-09 PH PH12020500673A patent/PH12020500673A1/en unknown
- 2020-12-11 CL CL2020003219A patent/CL2020003219A1/es unknown
- 2020-12-17 DO DO2020000249A patent/DOP2020000249A/es unknown
-
2021
- 2021-08-03 US US17/392,356 patent/US12365655B2/en active Active
-
2024
- 2024-07-05 JP JP2024108906A patent/JP7692095B2/ja active Active
- 2024-12-10 AU AU2024278273A patent/AU2024278273A1/en active Pending
-
2025
- 2025-06-18 US US19/241,736 patent/US20260062393A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CU20200096A7 (es) | N-benzisoxazolil sulfonamidas como inhibidores de kat | |
| MX380394B (es) | Compuesto novedoso de bifenilo o una sal del mismo. | |
| MX2022006783A (es) | Nuevos derivados de metilquinazolinona. | |
| CL2019002204A1 (es) | Compuestos inhibidores del vih. | |
| CO2019005165A2 (es) | Compuesto de piridona como inhibidor de c-met | |
| EA201892450A1 (ru) | Ароматические сульфонамидные производные | |
| UY36314A (es) | NUEVOS COMPUESTOS ANTAGONISTAS DE INTEGRINA avß6. | |
| EA201792021A1 (ru) | Ингибитор jak | |
| CL2016001458A1 (es) | Derivado de sulfonamida o sales de adición de ácido farmaceuticamente aceptables del mismo. | |
| AR101995A1 (es) | COMPUESTOS ANTAGONISTAS DE INTEGRINA avb6 | |
| CR20160564A (es) | Dinucleótidos cíclicos como moduladores de sting | |
| EA201890308A1 (ru) | Замещенные азасоединения как ингибиторы irak-4 | |
| CL2017002090A1 (es) | Inhibidores selectivos de bace1 | |
| EA201891278A1 (ru) | Гетероциклические индолы для применения при инфекции, вызванной вирусом гриппа | |
| GT201400167A (es) | Nuevos derivados de bencil sulfonamida utiles como inhibidores de mogat-2 | |
| CL2018001067A1 (es) | Compuesto piranodipiridínico. | |
| SV2019005838A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
| CL2023000313A1 (es) | Forma sólida de un compuesto | |
| EA201990238A1 (ru) | ФОСФОРСОДЕРЖАЩИЕ ПРОЛЕКАРСТВА СТИМУЛЯТОРОВ sGC | |
| CO2022008127A2 (es) | Procesos e intermediario para la preparación de oxetan-2-ilmetanamina | |
| MX2021009261A (es) | Compuesto de fluorovinilbenzamida como inmunomodulador pd-l1. | |
| AR103354A1 (es) | INHIBIDORES DE 3-FLUORO-BENZONITRILO DE 11-b-HIDROXILASA | |
| MX2022001044A (es) | Inhibidor de sglt2/dpp4 y su aplicacion. | |
| AR125853A2 (es) | Composición farmacéutica de una sal hemisulfato de un compuesto nucleotídico | |
| AR115865A2 (es) | Compuestos terapéuticos |